Find RGI-2001 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Krn7000, 158021-47-7, Krn 7000, Krn-7000, Alpha-galactosylceramide, .alpha.-galcer
Molecular Formula
C50H99NO9
Molecular Weight
858.3  g/mol
InChI Key
VQFKFAKEUMHBLV-BYSUZVQFSA-N
FDA UNII
WX671898JF

RGI-2001
Alpha Galactosylceramide is a potent alpha galactosylceramide modified from marine-sponge that stimulates the immune system to exhibit antitumor activity.
1 2D Structure

RGI-2001

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide
2.1.2 InChI
InChI=1S/C50H99NO9/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-25-26-27-29-31-33-35-37-39-45(54)51-42(41-59-50-49(58)48(57)47(56)44(40-52)60-50)46(55)43(53)38-36-34-32-30-28-16-14-12-10-8-6-4-2/h42-44,46-50,52-53,55-58H,3-41H2,1-2H3,(H,51,54)/t42-,43+,44+,46-,47-,48-,49+,50-/m0/s1
2.1.3 InChI Key
VQFKFAKEUMHBLV-BYSUZVQFSA-N
2.1.4 Canonical SMILES
CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C(CCCCCCCCCCCCCC)O)O
2.1.5 Isomeric SMILES
CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)[C@@H]([C@@H](CCCCCCCCCCCCCC)O)O
2.2 Other Identifiers
2.2.1 UNII
WX671898JF
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Krn 7000

2. Krn 7000, 1s-(1r*,2r*,3s*)-beta-d-galacto Isomer

3. Krn-7000

4. Krn7000

2.3.2 Depositor-Supplied Synonyms

1. Krn7000

2. 158021-47-7

3. Krn 7000

4. Krn-7000

5. Alpha-galactosylceramide

6. .alpha.-galcer

7. Ccris 8968

8. Agl-582

9. Galalpha-cer(t18:0/26:0)

10. Chebi:466659

11. 1-o-(alpha-d-galactopyranosyl)-n-hexacosanoylphytosphingosine

12. Alpha-galcer(t18:0/26:0)

13. Wx671898jf

14. Rgi-7000

15. (2s,3s,4r)-1-o-(alpha-d-galactosyl)-n-hexacosanoyl-2-amino-1,3,4-octadecanetriol

16. N-{(1s,2r,3s)-1-[(alpha-d-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}hexacosanamide

17. N-[(2s,3s,4r)-1-(alpha-d-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide

18. N-((2s,3s,4r)-3,4-dihydroxy-1-(((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)octadecan-2-yl)hexacosanamide

19. Unii-wx671898jf

20. Rgi-2001

21. Alpha-gc(c26)

22. Alpha-gc (c26)

23. Alpha-galactosyl Ceramide

24. Epitope Id:130694

25. Schembl512949

26. Chembl384200

27. Dtxsid40935847

28. Chemid158021477

29. Glxc-26234

30. Ex-a5755

31. Mfcd00939559

32. Zinc87496076

33. Db12232

34. Ac-31508

35. N-[(2s,3s,4r)-3,4-dihydroxy-1-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide

36. C16892

37. Alpha-galactosylceramide(a-gal-cer) (synthetic)

38. Q27105159

39. 1-o-(alpha-d-galactosyl)-n-hexacosanoylphytosphingosine

40. (2s,3s,4r)-1-o-(alpha-d-galactosyl)-n-hexacosanoyl-2-amino-1,3,4-octadecanetriol, >=95% (tlc)

41. Hexacosanamide, N-((1s,2s,3r)-1-((.alpha.-d-galactopyranosyloxy)methyl)-2,3-dihydroxyheptadecyl)-

42. Hexacosanamide, N-(1-((alpha-d-galactopyranosyloxy)methyl)-2,3-dihdyroxyheptadecyl)-, (1s-(1r*,2r*,3s*))-

43. Hexacosanamide, N-[(1s,2s,3r)-1-[(alpha-d-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-

44. Hexacosanamide, N-[(1s,2s,3r)-1-[(alpha-d-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]- (9ci)

45. Hexacosanamide, N-[1-[(alpha-d-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-, [1s-(1r*,2r*,3s*)]-

46. N-((2s,3s,4r)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)octadecan-2-yl)hexaicosanamide

47. N-{(1s,2s,3r)-1-[(alpha-d-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}hexacosanamide

48. Wurcs=2.0/1,1,0/[a2112h-1a_1-5_1*occ^sc^sc^rcccccccccccccc/6o/5o/4ncccccccccccccccccccccccccc/24=o]/1/

2.4 Create Date
2005-07-20
3 Chemical and Physical Properties
Molecular Weight 858.3 g/mol
Molecular Formula C50H99NO9
XLogP316
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count9
Rotatable Bond Count44
Exact Mass857.73198374 g/mol
Monoisotopic Mass857.73198374 g/mol
Topological Polar Surface Area169 Ų
Heavy Atom Count60
Formal Charge0
Complexity928
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Adjuvants, Immunologic

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)


Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


ABOUT THIS PAGE

Looking for 158021-47-7 / RGI-2001 API manufacturers, exporters & distributors?

RGI-2001 manufacturers, exporters & distributors 1

25

PharmaCompass offers a list of RGI-2001 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right RGI-2001 manufacturer or RGI-2001 supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred RGI-2001 manufacturer or RGI-2001 supplier.

PharmaCompass also assists you with knowing the RGI-2001 API Price utilized in the formulation of products. RGI-2001 API Price is not always fixed or binding as the RGI-2001 Price is obtained through a variety of data sources. The RGI-2001 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

RGI-2001

Synonyms

Krn7000, 158021-47-7, Krn 7000, Krn-7000, Alpha-galactosylceramide, .alpha.-galcer

Cas Number

158021-47-7

Unique Ingredient Identifier (UNII)

WX671898JF

About RGI-2001

Alpha Galactosylceramide is a potent alpha galactosylceramide modified from marine-sponge that stimulates the immune system to exhibit antitumor activity.

alpha-Galactosyl Ceramide Manufacturers

A alpha-Galactosyl Ceramide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of alpha-Galactosyl Ceramide, including repackagers and relabelers. The FDA regulates alpha-Galactosyl Ceramide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. alpha-Galactosyl Ceramide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

alpha-Galactosyl Ceramide Suppliers

A alpha-Galactosyl Ceramide supplier is an individual or a company that provides alpha-Galactosyl Ceramide active pharmaceutical ingredient (API) or alpha-Galactosyl Ceramide finished formulations upon request. The alpha-Galactosyl Ceramide suppliers may include alpha-Galactosyl Ceramide API manufacturers, exporters, distributors and traders.

click here to find a list of alpha-Galactosyl Ceramide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

alpha-Galactosyl Ceramide USDMF

A alpha-Galactosyl Ceramide DMF (Drug Master File) is a document detailing the whole manufacturing process of alpha-Galactosyl Ceramide active pharmaceutical ingredient (API) in detail. Different forms of alpha-Galactosyl Ceramide DMFs exist exist since differing nations have different regulations, such as alpha-Galactosyl Ceramide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A alpha-Galactosyl Ceramide DMF submitted to regulatory agencies in the US is known as a USDMF. alpha-Galactosyl Ceramide USDMF includes data on alpha-Galactosyl Ceramide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The alpha-Galactosyl Ceramide USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of alpha-Galactosyl Ceramide suppliers with USDMF on PharmaCompass.

alpha-Galactosyl Ceramide GMP

alpha-Galactosyl Ceramide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of alpha-Galactosyl Ceramide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right alpha-Galactosyl Ceramide GMP manufacturer or alpha-Galactosyl Ceramide GMP API supplier for your needs.

alpha-Galactosyl Ceramide CoA

A alpha-Galactosyl Ceramide CoA (Certificate of Analysis) is a formal document that attests to alpha-Galactosyl Ceramide's compliance with alpha-Galactosyl Ceramide specifications and serves as a tool for batch-level quality control.

alpha-Galactosyl Ceramide CoA mostly includes findings from lab analyses of a specific batch. For each alpha-Galactosyl Ceramide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

alpha-Galactosyl Ceramide may be tested according to a variety of international standards, such as European Pharmacopoeia (alpha-Galactosyl Ceramide EP), alpha-Galactosyl Ceramide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (alpha-Galactosyl Ceramide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty